Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Lixte Biotechnology Holdings, Inc. (LIXT) had Non-Operating Income/Expense of $-0.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.94M |
|
-- |
|
-- |
|
$1.99M |
|
$-1.99M |
|
|
Non-Operating Income/Expense |
$-0.00M |
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
10.89M |
|
10.89M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$3.41M |
|
-- |
|
$7.46M |
|
$10.87M |
|
$1.22M |
|
-- |
|
$0.46M |
|
$1.69M |
|
$9.18M |
|
$9.18M |
|
$9.18M |
|
11.63M |
|
| Cash Flow Statement Financials | |
$-1.83M |
|
$-0.02M |
|
-- |
|
$5.11M |
|
$3.25M |
|
$-1.86M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.65% |
|
-21.65% |
|
-18.29% |
|
-21.65% |
|
$0.79 |
|
$-0.17 |
|
$-0.17 |
|